大樹

-1.00 (-1.49%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

66.10527成交張數19.22本益比2.70股價淨值比5.68%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度	單季 EPS	年增	近四季 EPS	歸屬母公司淨利(億)	淨利率	ROE(季)	ROE(近四季)
2026Q2	0.79	-22.1%	3.33	1.10	2.3%	3.05%	14.45%
2026Q1	0.78	-22.5%	3.56	1.25	2.6%	3.35%	16.43%
2025Q4	0.93	-15.3%	3.78	1.49	3.1%	3.91%	15.98%
2025Q3	0.83	19.5%	3.95	1.31	2.9%	3.65%	17.67%
2025Q2	1.01	-30.0%	3.82	1.60	3.4%	4.72%	19.77%
2025Q1	1.01	-5.6%	4.25	1.60	3.4%	4.62%	21.07%
2024Q4	1.10	-3.5%	4.31	1.74	3.9%	5.01%	19.79%
2024Q3	0.69	21.4%	4.35	1.67	3.9%	5.06%	21.58%
2024Q2	1.44	-7.4%	4.23	1.70	4.0%	5.41%	23.72%
2024Q1	1.07	5.9%	4.34	1.69	4.0%	5.33%	25.11%
2023Q4	1.14	4.5%	4.28	1.79	4.3%	5.72%	22.65%
2023Q3	0.57	-48.3%	4.23	1.63	4.0%	5.95%	24.41%
2023Q2	1.56	-2.2%	4.77	1.67	4.1%	6.86%	28.47%
2023Q1	1.01	31.0%	4.80	1.57	4.1%	6.34%	34.99%
2022Q4	1.09	47.7%	4.56	1.68	4.4%	6.74%	30.89%
2022Q3	1.10	59.1%	4.21	1.69	4.7%	7.50%	30.84%
2022Q2	1.59	103.2%	3.80	2.44	6.2%	12.21%	30.05%
2022Q1	0.77	61.7%	2.99	1.18	3.7%	6.19%	26.20%
2021Q4	0.74	85.3%	2.70	1.12	3.7%	6.05%	23.75%
2021Q3	0.69	133.6%	2.36	1.05	3.6%	5.96%	22.11%
2021Q2	0.78	156.2%	1.96	1.18	4.2%	7.15%	19.33%
2021Q1	0.48	46.0%	1.48	0.72	2.9%	4.66%	15.43%
2020Q4	0.40	56.9%	1.33	0.59	2.5%	4.07%	14.39%
2020Q3	0.30	9.4%	1.18	0.45	2.0%	3.29%	13.46%
2020Q2	0.31	13.0%	1.16	0.44	2.2%	3.39%	14.05%
2020Q1	0.33	74.2%	1.12	0.46	2.3%	3.73%	13.66%
2019Q4	0.25	-2.2%	0.98	0.36	2.0%	3.13%	12.08%
2019Q3	0.27	40.5%	0.99	0.37	2.2%	3.49%	12.58%
2019Q2	0.27	51.1%	0.91	0.37	2.3%	3.62%	13.72%
2019Q1	0.19	7.4%	0.82	0.26	1.7%	2.48%	11.84%
2018Q4	0.26	0.6%	0.81	0.35	2.5%	3.37%	11.42%
2018Q3	0.19	-18.8%	0.81	0.27	2.1%	2.99%	11.64%
2018Q2	0.18	3.7%	0.85	0.22	1.9%	2.66%	13.86%
2018Q1	0.17	29.2%	0.84	0.22	2.1%	2.73%	13.59%
2017Q4	0.26	21.7%	0.81	0.33	3.3%	4.19%	13.29%
2017Q3	0.24	15.6%	0.76	0.30	3.2%	3.98%	13.01%
2017Q2	0.17	13.2%	0.73	0.22	2.5%	2.95%	12.99%
2017Q1	0.14	–	–	0.17	2.1%	2.31%	–
2016Q4	0.21	–	–	0.27	3.4%	3.73%	–
2016Q3	0.21	–	–	0.26	3.7%	3.77%	–